Related Experiment Video
Updated: Aug 1, 2026

Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Triggering Receptor Expressed on Myeloid Cell 2-Mediated Microglial Phagocytosis in the Subacute Phase of Traumatic
Jing Xia1,2,3, Chen-Yu Sun1,2,3, Ting Su1,2,3
1NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou, China.
Abstract:
Traumatic brain injury (TBI) induces severe neuropsychiatric complications. Triggering receptor expressed on myeloid cells 2 (TREM2) is essential for microglial-mediated synaptic engulfment. This study aimed to clarify the unique role played by microglial TREM2 in memory dysfunction during the subacute phase of TBI. Behavior tests were conducted to assess post-TBI memory impairment in male Sprague-Dawley (SD) rats. The activity of microglia in different phases of TBI was observed via detecting Iba1 immunoreactivity by immunofluorescence and microglial markers by quantitative reverse transcription polymerase chain reaction. Pharmacological inhibition of microglia regulates its activity during the subacute phase. Additionally, we employed male Trem2 knockout mice in the C57BL/6J genetic background, as well as male wild-type C57BL/6J mice subjected to brain stereotaxic injection of TREM2 small interfering RNA. Rats subjected to TBI showed impaired memory retention in the Morris water maze test. Microglia activation and TREM2 expression peaked in the subacute phase, especially in Cornu Ammonis1 (CA1). Pharmacological inhibition of microglia in SD rats attenuated cell apoptosis and synaptic loss caused by TBI. Further studies demonstrated that selective knockdown of TREM2 in CA1 reduced microglia-mediated phagocytosis of synapses and enhanced synaptic plasticity, improving memory dysfunction associated with TBI. Our findings suggest that upregulation of TREM2 exacerbated TBI-induced memory dysfunction by promoting excessive microglial phagocytosis and synaptic loss in the subacute phase.
Insights
Traumatic brain injury (TBI) causes memory loss. Upregulated TREM2 in microglia worsens TBI memory dysfunction by increasing synapse loss during the subacute phase.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Traumatic brain injury (TBI) leads to significant neuropsychiatric issues.
- Microglia, the brain's immune cells, play a crucial role in TBI.
- TREM2 (Triggering Receptor Expressed on Myeloid cells 2) is vital for microglial functions like synaptic pruning.
Purpose of the Study:
- To investigate the specific role of microglial TREM2 in memory deficits following TBI during the subacute phase.
- To understand how TREM2 influences microglial activity and synaptic integrity post-TBI.
Main Methods:
- Behavioral tests (Morris water maze) assessed memory in TBI rats.
- Immunofluorescence (Iba1) and qPCR quantified microglial activation and TREM2 expression.
- TREM2 was inhibited using small interfering RNA (siRNA) in wild-type mice and studied in Trem2 knockout mice.
Main Results:
- TBI rats exhibited significant memory impairment.
- Microglial activation and TREM2 expression peaked in the subacute phase, particularly in the CA1 region.
- Inhibition of microglial activity and TREM2 knockdown in CA1 reduced synaptic loss, enhanced synaptic plasticity, and improved memory function.
Conclusions:
- Microglial TREM2 upregulation exacerbates TBI-induced memory dysfunction.
- Excessive microglial phagocytosis of synapses, mediated by TREM2, contributes to memory deficits in the subacute phase of TBI.
- Targeting microglial TREM2 may offer therapeutic potential for TBI-related memory impairments.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Neurogenesis and Regeneration of Nervous Tissue
Role of Amygdala in Memory
One of the...
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

